Cargando…

1789. Current Antibiotic Prescription Practices in Hospitalized Patients with Acute Myeloid Leukemia (AML) and Febrile Neutropenia of Unknown Origin (FN-FUO): Data from a Large Tertiary Community Hospital

BACKGROUND: Optimal duration of empiric antibiotic therapy in hospitalized patients with febrile neutropenia of unknown origin (FN-FUO) remains controversial. Emerging evidence suggests that early discontinuation of antibiotics at 48-72 hours of apyrexia is safe regardless of neutrophil count. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portales-Castillo, Carlos, Laguio-Vila, Maryrose R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752911/ http://dx.doi.org/10.1093/ofid/ofac492.1419

Ejemplares similares

Fever of unknown origin (FUO) revised
por: Unger, Manuel, et al.
Publicado: (2016)

Extensive Fever of Unknown Origin (FUO) Workup to Unmask Pheochromocytoma
por: Rai, Harpreet K, et al.
Publicado: (2021)

1782. Antimicrobial Stewardship Opportunities in Gram-Negative Bacteremia Treatment at a Community Teaching Hospital
por: Ficinski, Matthew, et al.
Publicado: (2022)

A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023)

Human Herpes Viruses Are Associated with Classic Fever of Unknown Origin (FUO) in Beijing Patients
por: Zhou, Weimin, et al.
Publicado: (2014)

The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)
por: Di Francesco, Angela Maria, et al.
Publicado: (2021)

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
por: Aapro, Matti S., et al.
Publicado: (2023)

Correction: Human Herpes Viruses Are Associated with Classic Fever of Unknown Origin (FUO) in Beijing Patients
Publicado: (2014)

Fever of unknown origin (FUO) in children: a single-centre experience from Beijing, China
por: Hu, Bing, et al.
Publicado: (2022)

D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia
por: Rattanathammethee, Thanawat, et al.
Publicado: (2023)

Investigator-Determined Categories for Fever of Unknown Origin (FUO) Compared With International Classification of Diseases–10 Classification of Illness: A Systematic Review and Meta-analysis With a Proposal for Revised FUO Classification
por: Wright, William F, et al.
Publicado: (2023)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
por: Bachlitzanaki, Maria, et al.
Publicado: (2023)

Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study
por: Ishikawa, Takashi, et al.
Publicado: (2021)

Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review
por: Fusco, Francesco Maria, et al.
Publicado: (2019)

Place of the (18)F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)
por: Letertre, Simon, et al.
Publicado: (2021)

Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review
por: Minamimoto, Ryogo
Publicado: (2022)

1154. Characterizing fungemic outcomes among adult inpatients at a community teaching hospital: a retrospective cohort study
por: Staicu, Mary L, et al.
Publicado: (2020)

Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
por: Salako, Omolola, et al.
Publicado: (2021)

The Application of Whole−Exome Sequencing in Patients With FUO
por: Guo, Wanru, et al.
Publicado: (2022)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

Recurrent Fever of Unknown Origin (FUO) Due to Periodic Fever, Aphthous Stomatititis, Pharyngitis and Adenitis (FAPA) Syndrome in an Adult
por: Muñoz-Gómez, Sigridh, et al.
Publicado: (2013)

Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia
por: Rosa, Regis G., et al.
Publicado: (2014)

Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia
por: Baugh, Christopher W., et al.
Publicado: (2019)

Comparison of the etiologic, microbiologic, clinical and outcome characteristics of febrile vs. non-febrile neutropenia in hospitalized immunocompetent children
por: Leibovitz, Eugene, et al.
Publicado: (2020)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Voriconazole-induced psychosis in a case of acute myeloid leukemia with febrile neutropenia
por: Singh, Hemendra, et al.
Publicado: (2015)

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
por: Rapoport, Bernardo Leon, et al.
Publicado: (2018)

Knowledge and Perspectives of Antimicrobial Stewardship: A Comparison of Inpatient vs. Outpatient Providers
por: Datta, Siddhant, et al.
Publicado: (2017)

190. Which antibiotic are you? Evaluation of a global antibiotic awareness personality quiz
por: Langford, Bradley J, et al.
Publicado: (2020)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

446 Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia
por: Rosa, Regis, et al.
Publicado: (2014)

Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital
por: Mohammed, Husnia Bedewi, et al.
Publicado: (2019)

Prevalence of malignancy in patients with fever of unknown origin (FUO) demonstrated in 18F-FDG PET-CT – prospective multi-centre study
por: Sonoda, LI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1th80oe94jg4rld80ntng3lccj